Sarepta Therapeutics IncNASDAQ:SRPT
- LAST PRICE126.0000
- TODAY'S CHANGE (%)-1.7800 (-1.3930%)
- Bid / Lots123.0000/ 1
- Ask / Lots131.5000/ 1
- Open / Previous Close127.3200 / 127.7800
- Day Range
- 52 Week Range
- Volume652,347
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | SRPT |
|---|---|---|
| 09:32 ET | 5976 | 127.73 |
| 09:34 ET | 100 | 127.35 |
| 09:36 ET | 700 | 126.89 |
| 09:39 ET | 1000 | 127.32 |
| 09:41 ET | 409 | 127.405 |
| 09:43 ET | 2600 | 127.55 |
| 09:45 ET | 1355 | 127.53 |
| 09:48 ET | 1407 | 127.28 |
| 09:50 ET | 2684 | 127.32 |
| 09:54 ET | 1700 | 126.21 |
| 09:56 ET | 654 | 126.41 |
| 09:57 ET | 2166 | 126.09 |
| 09:59 ET | 1575 | 126.03 |
| 10:01 ET | 1200 | 126.08 |
| 10:03 ET | 1181 | 126.385 |
| 10:06 ET | 8184 | 126.24 |
| 10:08 ET | 14839 | 126.765 |
| 10:10 ET | 443 | 126.79 |
| 10:12 ET | 100 | 127.095 |
| 10:15 ET | 1000 | 127.245 |
| 10:19 ET | 960 | 128.004 |
| 10:24 ET | 200 | 127.99 |
| 10:26 ET | 200 | 128 |
| 10:30 ET | 500 | 127.885 |
| 10:32 ET | 1042 | 127.63 |
| 10:33 ET | 2188 | 127.58 |
| 10:35 ET | 400 | 127.38 |
| 10:37 ET | 150 | 127.41 |
| 10:39 ET | 100 | 127.255 |
| 10:42 ET | 1100 | 127 |
| 10:44 ET | 805 | 127.06 |
| 10:46 ET | 100 | 127.24 |
| 10:48 ET | 100 | 127.085 |
| 10:50 ET | 900 | 127.125 |
| 10:53 ET | 576 | 127.08 |
| 10:55 ET | 1979 | 126.87 |
| 10:57 ET | 1668 | 126.575 |
| 11:00 ET | 1574 | 126.4 |
| 11:02 ET | 1813 | 126.63 |
| 11:04 ET | 589 | 126.4 |
| 11:06 ET | 700 | 126.67 |
| 11:08 ET | 400 | 126.57 |
| 11:09 ET | 936 | 126.59 |
| 11:11 ET | 301 | 126.665 |
| 11:13 ET | 400 | 126.59 |
| 11:15 ET | 500 | 126.64 |
| 11:18 ET | 500 | 126.84 |
| 11:20 ET | 300 | 126.95 |
| 11:22 ET | 1000 | 127.04 |
| 11:26 ET | 100 | 127.38 |
| 11:27 ET | 304 | 127.035 |
| 11:29 ET | 100 | 127.04 |
| 11:31 ET | 500 | 126.915 |
| 11:33 ET | 2425 | 126.72 |
| 11:36 ET | 637 | 126.82 |
| 11:38 ET | 1000 | 127.035 |
| 11:40 ET | 200 | 127.3 |
| 11:45 ET | 200 | 127.47 |
| 11:47 ET | 700 | 127.545 |
| 11:49 ET | 1296 | 127.29 |
| 11:51 ET | 700 | 127.41 |
| 11:54 ET | 100 | 127.355 |
| 11:56 ET | 640 | 127.25 |
| 11:58 ET | 100 | 127.24 |
| 12:00 ET | 200 | 127.285 |
| 12:02 ET | 345 | 127.29 |
| 12:03 ET | 1500 | 127.48 |
| 12:05 ET | 1314 | 127.48 |
| 12:07 ET | 800 | 127.5 |
| 12:09 ET | 200 | 127.34 |
| 12:12 ET | 1050 | 127.45 |
| 12:14 ET | 100 | 127.29 |
| 12:16 ET | 100 | 127.5 |
| 12:18 ET | 100 | 127.39 |
| 12:20 ET | 1100 | 127.32 |
| 12:21 ET | 1040 | 127.6 |
| 12:23 ET | 100 | 127.53 |
| 12:25 ET | 200 | 127.58 |
| 12:27 ET | 300 | 127.52 |
| 12:30 ET | 400 | 127.71 |
| 12:34 ET | 430 | 127.77 |
| 12:38 ET | 200 | 127.56 |
| 12:41 ET | 1274 | 127.56 |
| 12:43 ET | 469 | 127.545 |
| 12:45 ET | 100 | 127.49 |
| 12:48 ET | 100 | 127.6 |
| 12:50 ET | 659 | 127.38 |
| 12:52 ET | 400 | 127.29 |
| 12:54 ET | 500 | 127.31 |
| 12:56 ET | 724 | 127.36 |
| 12:57 ET | 100 | 127.325 |
| 12:59 ET | 400 | 127.4 |
| 01:01 ET | 358 | 127.44 |
| 01:03 ET | 515 | 127.49 |
| 01:06 ET | 200 | 127.465 |
| 01:10 ET | 400 | 127.4 |
| 01:12 ET | 1421 | 127.615 |
| 01:14 ET | 1010 | 127.415 |
| 01:15 ET | 200 | 127.4 |
| 01:17 ET | 1160 | 127.635 |
| 01:19 ET | 500 | 127.47 |
| 01:21 ET | 100 | 127.64 |
| 01:24 ET | 200 | 127.645 |
| 01:26 ET | 690 | 127.54 |
| 01:28 ET | 100 | 127.555 |
| 01:30 ET | 328 | 127.45 |
| 01:32 ET | 561 | 127.335 |
| 01:33 ET | 507 | 127.22 |
| 01:35 ET | 300 | 127.2 |
| 01:37 ET | 100 | 127.195 |
| 01:39 ET | 100 | 127.3399 |
| 01:42 ET | 200 | 127.15 |
| 01:44 ET | 200 | 127.22 |
| 01:46 ET | 200 | 127.3 |
| 01:48 ET | 1443 | 127.06 |
| 01:50 ET | 400 | 127.115 |
| 01:53 ET | 100 | 127.025 |
| 01:55 ET | 300 | 127.18 |
| 01:57 ET | 908 | 127.32 |
| 02:00 ET | 1200 | 127.36 |
| 02:02 ET | 500 | 127.345 |
| 02:06 ET | 100 | 127.35 |
| 02:08 ET | 400 | 127.45 |
| 02:09 ET | 650 | 127.5771 |
| 02:11 ET | 100 | 127.44 |
| 02:13 ET | 900 | 127.37 |
| 02:15 ET | 500 | 127.42 |
| 02:18 ET | 441 | 127.29 |
| 02:20 ET | 200 | 127.15 |
| 02:22 ET | 1103 | 127.25 |
| 02:24 ET | 400 | 127.195 |
| 02:26 ET | 1200 | 127.185 |
| 02:27 ET | 1000 | 127.12 |
| 02:29 ET | 1232 | 127.065 |
| 02:31 ET | 1534 | 126.89 |
| 02:33 ET | 100 | 126.945 |
| 02:36 ET | 700 | 126.905 |
| 02:38 ET | 1860 | 127.065 |
| 02:40 ET | 700 | 126.995 |
| 02:42 ET | 2100 | 126.7 |
| 02:44 ET | 100 | 126.7 |
| 02:45 ET | 412 | 126.81 |
| 02:47 ET | 200 | 126.68 |
| 02:49 ET | 500 | 126.73 |
| 02:51 ET | 600 | 126.71 |
| 02:54 ET | 597 | 126.825 |
| 02:58 ET | 400 | 126.78 |
| 03:00 ET | 1048 | 126.91 |
| 03:02 ET | 127 | 126.915 |
| 03:03 ET | 600 | 126.905 |
| 03:05 ET | 424 | 126.84 |
| 03:07 ET | 1100 | 126.87 |
| 03:09 ET | 637 | 126.82 |
| 03:12 ET | 207 | 126.9899 |
| 03:14 ET | 708 | 126.8975 |
| 03:18 ET | 1700 | 126.89 |
| 03:20 ET | 500 | 126.93 |
| 03:21 ET | 429 | 126.94 |
| 03:23 ET | 459 | 126.81 |
| 03:25 ET | 1000 | 126.885 |
| 03:27 ET | 594 | 126.69 |
| 03:30 ET | 740 | 126.61 |
| 03:32 ET | 5376 | 126.6 |
| 03:34 ET | 1037 | 126.585 |
| 03:36 ET | 2600 | 126.67 |
| 03:38 ET | 974 | 126.6525 |
| 03:39 ET | 497 | 126.815 |
| 03:41 ET | 3768 | 126.7 |
| 03:43 ET | 2817 | 126.775 |
| 03:45 ET | 2312 | 127.075 |
| 03:48 ET | 2181 | 127.01 |
| 03:50 ET | 1673 | 126.9 |
| 03:52 ET | 13740 | 126.91 |
| 03:54 ET | 3463 | 126.74 |
| 03:56 ET | 9900 | 126.43 |
| 03:57 ET | 10263 | 126.17 |
| 03:59 ET | 149695 | 126 |
Today
Oct 23, 2024
Press Release: Sarepta Therapeutics to Announce Third Quarter 2024 Financial Results, from 8:31AM ET on Wednesday Oct 23, 2024 by Dow Jones
8:31AM ET on Wednesday Oct 23, 2024 by Dow JonesSarepta Therapeutics to Announce Third Quarter 2024 Financial Results, from 8:30AM ET on Wednesday Oct 23, 2024 by Dow Jones
8:30AM ET on Wednesday Oct 23, 2024 by Dow Jones
Oct 22, 2024
DJ S&P 500 Futures Fall In Premarket Trading; Range Resources, Mueller Industries Lead, from 7:30AM ET on Tuesday Oct 22, 2024 by Dow Jones
7:30AM ET on Tuesday Oct 22, 2024 by Dow Jones
Oct 21, 2024
DJ Sarepta Therapeutics Price Target Maintained With a $182.00/Share by RBC Capital, from 10:11AM ET on Monday Oct 21, 2024 by Dow Jones
10:11AM ET on Monday Oct 21, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Sarepta Therapeutics Inc | 12.2B | 302.3x | --- |
Bio-Techne Corp | 12.1B | 72.8x | +11.13% |
Neurocrine Biosciences Inc | 12.6B | 36.3x | +62.04% |
Insmed Inc | 12.1B | -12.5x | --- |
Medpace Holdings Inc | 9.9B | 27.5x | +35.10% |
Exelixis Inc | 9.3B | 21.2x | -21.77% |
Company Information
Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company. The Company is focused on helping patients through the discovery and development of ribonucleic acid (RNA)-targeted therapeutics, gene therapy and other genetic therapeutic modalities for the treatment of rare diseases. It has developed multiple approved products for the treatment of Duchenne muscular dystrophy (Duchenne) and is developing potential therapeutic candidates for a range of diseases and disorders, including Duchenne, Limb-girdle muscular dystrophies (LGMDs) and other neuromuscular and central nervous system (CNS) related disorders. It has developed and commercialized four approved products for the treatment of Duchenne: EXONDYS 51 (eteplirsen), Injection (EXONDYS 51), VYONDYS 53 (golodirsen) Injection (VYONDYS 53), AMONDYS 45 (casimersen) Injection (AMONDYS 45), and ELEVIDYS. Its pipeline includes approximately 40 programs at various stages of discovery, pre-clinical and clinical development.
Contact Information
- Headquarters
- 215 1st St Ste 415CAMBRIDGE, MA, United States 02142-1213
- Phone
- 617-274-4000
- Fax
- 302-636-5454
Executives
- Independent Chairwoman of the Board
- M. Kathleen Behrens
- President, Chief Executive Officer, Director
- Douglas Ingram
- Chief Financial Officer, Executive Vice President
- Ian Estepan
- Executive Vice President, Chief Scientific Officer, Head of R and D
- Louise Rodino-Klapac
- Executive Vice President, General Counsel, Corporate Secretary
- Ryan Brown
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $12.2B |
|---|---|
Revenue (TTM) | $1.5B |
Shares Outstanding | 95.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.80 |
EPS | $0.42 |
Book Value | $9.17 |
P/E Ratio | 302.3x |
Price/Sales (TTM) | 8.1 |
Price/Cash Flow (TTM) | 140.0x |
Operating Margin | 0.53% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
